📗 Cite This Artifact
Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP
Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP
Overview
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP</th>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Target Region</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Piriform cortex</td>
</tr>
<tr>
<td class="label">Olfactory tract</td>
<td>Limbic system (amygdala, hippocampus)</td>
</tr>
<tr>
<td class="label">Secondary olfactory areas</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">Orbitofrontal cortex</td>
<td>Higher-order olfactory integration</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>CBS</td>
</tr>
<tr>
<td class="label">Olfactory loss prevalence</td>
<td>60-70%</td>
</tr>
<tr>
<td class="label">Onset relative to motor symptoms</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Correlation with disease severity</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Odor identification impairment</td>
<td>Severe</td>
</tr>
<tr>
<td class="label">Effect</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Parasympathetic activation</td>
<td>Vagal nuclei stimulation</td>
</tr>
<tr>
<td class="label">Blood pressure modulation</td>
<td>Hypothalamic integration</td>
</tr>
<tr>
<td class="label">Respiratory regulation</td>
<td>Brainstem centers</td>
</tr>
<tr>
<td class="label">Elec
Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP
Overview
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP</th>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Target Region</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Piriform cortex</td>
</tr>
<tr>
<td class="label">Olfactory tract</td>
<td>Limbic system (amygdala, hippocampus)</td>
</tr>
<tr>
<td class="label">Secondary olfactory areas</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">Orbitofrontal cortex</td>
<td>Higher-order olfactory integration</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>CBS</td>
</tr>
<tr>
<td class="label">Olfactory loss prevalence</td>
<td>60-70%</td>
</tr>
<tr>
<td class="label">Onset relative to motor symptoms</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Correlation with disease severity</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Odor identification impairment</td>
<td>Severe</td>
</tr>
<tr>
<td class="label">Effect</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Parasympathetic activation</td>
<td>Vagal nuclei stimulation</td>
</tr>
<tr>
<td class="label">Blood pressure modulation</td>
<td>Hypothalamic integration</td>
</tr>
<tr>
<td class="label">Respiratory regulation</td>
<td>Brainstem centers</td>
</tr>
<tr>
<td class="label">Electrodermal activity</td>
<td>Sympathetic modulation</td>
</tr>
<tr>
<td class="label">Compound Class</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Terpenes</td>
<td>Limonene, pinene</td>
</tr>
<tr>
<td class="label">Phenylpropanoids</td>
<td>Eugenol, cinnamaldehyde</td>
</tr>
<tr>
<td class="label">Sesquiterpenes</td>
<td>Chamazulene, farnesol</td>
</tr>
<tr>
<td class="label">Aldehydes</td>
<td>Citral, citronellal</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Primary Compounds</td>
</tr>
<tr>
<td class="label">Lavender (Lavandula angustifolia)</td>
<td>Linalool, linalyl acetate</td>
</tr>
<tr>
<td class="label">Peppermint (Mentha piperita)</td>
<td>Menthol, menthone</td>
</tr>
<tr>
<td class="label">Rosemary (Rosmarinus officinalis)</td>
<td>1,8-cineole, α-pinene</td>
</tr>
<tr>
<td class="label">Citrus (Citrus spp.)</td>
<td>Limonene, citral</td>
</tr>
<tr>
<td class="label">Ylang Ylang (Cananga odorata)</td>
<td>Benzyl acetate, linalool</td>
</tr>
<tr>
<td class="label">Frankincense (Boswellia spp.)</td>
<td>Boswellic acids, incensole</td>
</tr>
<tr>
<td class="label">Bergamot (Citrus bergamia)</td>
<td>Limonene, linalyl acetate</td>
</tr>
<tr>
<td class="label">Cedarwood (Cedrus atlantica)</td>
<td>Cedrol, sesquiterpenes</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Rosemary</td>
<td>Acetylcholinesterase inhibition</td>
</tr>
<tr>
<td class="label">Peppermint</td>
<td>Attention and alertness</td>
</tr>
<tr>
<td class="label">Citrus</td>
<td>Dopaminergic modulation</td>
</tr>
<tr>
<td class="label">Sage (Salvia officinalis)</td>
<td>Cholinergic support</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Lavender</td>
<td>GABA modulation</td>
</tr>
<tr>
<td class="label">Bergamot</td>
<td>Dopamine and serotonin</td>
</tr>
<tr>
<td class="label">Ylang Ylang</td>
<td>Serotonin modulation</td>
</tr>
<tr>
<td class="label">Frankincense</td>
<td>Limbic activation</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Lavender</td>
<td>Parasympathetic activation</td>
</tr>
<tr>
<td class="label">Ylang Ylang</td>
<td>Heart rate reduction</td>
</tr>
<tr>
<td class="label">Marjoram</td>
<td>Vagal tone enhancement</td>
</tr>
<tr>
<td class="label">Petitgrain</td>
<td>Nervous system calming</td>
</tr>
<tr>
<td class="label">Consideration</td>
<td>Recommendation</td>
</tr>
<tr>
<td class="label">Dilution</td>
<td>Always dilute (1-3% for topical)</td>
</tr>
<tr>
<td class="label">Quality</td>
<td>Use pure, organic essential oils</td>
</tr>
<tr>
<td class="label">Skin patch test</td>
<td>Test before widespread use</td>
</tr>
<tr>
<td class="label">Pregnancy</td>
<td>Avoid or consult physician</td>
</tr>
<tr>
<td class="label">Seizure history</td>
<td>Avoid excitatory oils (rosemary, peppermint)</td>
</tr>
<tr>
<td class="label">Respiratory conditions</td>
<td>Use in well-ventilated areas</td>
</tr>
<tr>
<td class="label">Pets</td>
<td>Ensure animal safety</td>
</tr>
<tr>
<td class="label">Medication interactions</td>
<td>Monitor for additive effects</td>
</tr>
<tr>
<td class="label">Parameter</td>
<td>Recommendation</td>
</tr>
<tr>
<td class="label">Duration</td>
<td>15-30 minutes, 2-3 times daily</td>
</tr>
<tr>
<td class="label">Oil amount</td>
<td>3-5 drops in water reservoir</td>
</tr>
<tr>
<td class="label">Room size</td>
<td>Adjust to room size</td>
</tr>
<tr>
<td class="label">Timing</td>
<td>Morning (citrus), evening (lavender)</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">Bottle method</td>
<td>3-5 deep breaths</td>
</tr>
<tr>
<td class="label">Tissue method</td>
<td>5-10 breaths</td>
</tr>
<tr>
<td class="label">Steam inhalation</td>
<td>5-10 minutes</td>
</tr>
<tr>
<td class="label">Application Area</td>
<td>Concentration</td>
</tr>
<tr>
<td class="label">Full body massage</td>
<td>1-2%</td>
</tr>
<tr>
<td class="label">Local application</td>
<td>2-3%</td>
</tr>
<tr>
<td class="label">Bath</td>
<td>5-10 drops</td>
</tr>
<tr>
<td class="label">Compress</td>
<td>2-3 drops</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">Upon waking</td>
<td>Peppermint</td>
</tr>
<tr>
<td class="label">Breakfast</td>
<td>Rosemary</td>
</tr>
<tr>
<td class="label">Mid-morning</td>
<td>Citrus blend</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">After dinner</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Pre-bed</td>
<td>Lavender + chamomile</td>
</tr>
<tr>
<td class="label">Sleep</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Meta-analysis</td>
<td>Post-viral olfactory loss</td>
</tr>
<tr>
<td class="label">RCT</td>
<td>Parkinson's disease</td>
</tr>
<tr>
<td class="label">Pilot</td>
<td>Alzheimer's disease</td>
</tr>
<tr>
<td class="label">Observational</td>
<td>Various dementia</td>
</tr>
<tr>
<td class="label">Phase</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">1</td>
<td>Weeks 1-4</td>
</tr>
<tr>
<td class="label">2</td>
<td>Weeks 5-8</td>
</tr>
<tr>
<td class="label">3</td>
<td>Weeks 9-12</td>
</tr>
<tr>
<td class="label">Adaptation</td>
<td>Rationale</td>
</tr>
<tr>
<td class="label">Shorter sessions</td>
<td>Fatigue</td>
</tr>
<tr>
<td class="label">Caregiver assistance</td>
<td>Motor impairment</td>
</tr>
<tr>
<td class="label">Visual cues</td>
<td>Memory difficulty</td>
</tr>
<tr>
<td class="label">Simplified selection</td>
<td>Cognitive impairment</td>
</tr>
<tr>
<td class="label">Extended timeline</td>
<td>Slower recovery</td>
</tr>
<tr>
<td class="label">Measure</td>
<td>Tool</td>
</tr>
<tr>
<td class="label">Olfactory function</td>
<td>UPSIT or Sniffin' Sticks</td>
</tr>
<tr>
<td class="label">Quality of life</td>
<td>Olfactory-specific QoL</td>
</tr>
<tr>
<td class="label">Mood</td>
<td>HADS</td>
</tr>
<tr>
<td class="label">Cognition</td>
<td>MoCA</td>
</tr>
<tr>
<td class="label">Therapy</td>
<td>Aromatherapy Addition</td>
</tr>
<tr>
<td class="label">Chair yoga</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Balance training</td>
<td>Peppermint</td>
</tr>
<tr>
<td class="label">Stretching</td>
<td>Eucalyptus</td>
</tr>
<tr>
<td class="label">Gait training</td>
<td>Rosemary</td>
</tr>
<tr>
<td class="label">Assessment</td>
<td>Purpose</td>
</tr>
<tr>
<td class="label">Olfactory function test</td>
<td>Baseline and monitoring</td>
</tr>
<tr>
<td class="label">Quality of life (SF-12)</td>
<td>General wellbeing</td>
</tr>
<tr>
<td class="label">Mood (HADS)</td>
<td>Emotional state</td>
</tr>
<tr>
<td class="label">Sleep diary</td>
<td>Sleep quality</td>
</tr>
<tr>
<td class="label">Practice log</td>
<td>Adherence tracking</td>
</tr>
<tr>
<td class="label">Concern</td>
<td>Signs</td>
</tr>
<tr>
<td class="label">Respiratory irritation</td>
<td>Cough, wheeze</td>
</tr>
<tr>
<td class="label">Skin sensitivity</td>
<td>Rash, irritation</td>
</tr>
<tr>
<td class="label">Allergic reaction</td>
<td>Hives, swelling</td>
</tr>
<tr>
<td class="label">CNS effects</td>
<td>Drowsiness, dizziness</td>
</tr>
<tr>
<td class="label">Interactions</td>
<td>Changed medication effects</td>
</tr>
<tr>
<td class="label">Date</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">RCT</td>
<td>PD (n=56)</td>
</tr>
<tr>
<td class="label">Meta-analysis</td>
<td>Olfactory loss</td>
</tr>
<tr>
<td class="label">Pilot</td>
<td>Dementia (n=30)</td>
</tr>
<tr>
<td class="label">Review</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Observational</td>
<td>CBS (n=18)</td>
</tr>
<tr>
<td class="label">Case series</td>
<td>PSP (n=12)</td>
</tr>
<tr>
<td class="label">Cross-sectional</td>
<td>CBS/PSP (n=45)</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Finding</td>
</tr>
<tr>
<td class="label">Cholinesterase inhibition</td>
<td>Rosemary inhibits AChE</td>
</tr>
<tr>
<td class="label">Neuroinflammation</td>
<td>Lavender reduces IL-6</td>
</tr>
<tr>
<td class="label">Neurogenesis</td>
<td>Olfactory training promotes neurogenesis</td>
</tr>
<tr>
<td class="label">Autonomic function</td>
<td>Essential oils modulate HRV</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">Safety</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Accessibility</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Evidence in CBS/PSP</td>
<td>2/10</td>
</tr>
<tr>
<td class="label">Evidence in PD</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Evidence in Neurodegeneration</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Cost</td>
<td>10/10</td>
</tr>
<tr>
<td class="label">Integration</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Sustainability</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Quality of Life</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">TOTAL</td>
<td>70/100</td>
</tr>
<tr>
<td class="label">Practice</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Aromatherapy</td>
<td>No direct interaction</td>
</tr>
<tr>
<td class="label">Olfactory training</td>
<td>May enhance cognitive function</td>
</tr>
<tr>
<td class="label">Relaxing oils</td>
<td>May complement motor benefits</td>
</tr>
<tr>
<td class="label">Medication</td>
<td>Consideration</td>
</tr>
<tr>
<td class="label">SSRIs</td>
<td>Safe with aromatherapy</td>
</tr>
<tr>
<td class="label">SNRIs</td>
<td>Safe</td>
</tr>
<tr>
<td class="label">MAO-Is</td>
<td>Monitor blood pressure with stimulating oils</td>
</tr>
<tr>
<td class="label">Tricyclics</td>
<td>Additive sedation possible</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Practice</td>
</tr>
<tr>
<td class="label">Morning</td>
<td>Cognitive oil (rosemary/peppermint)</td>
</tr>
<tr>
<td class="label">Midday</td>
<td>Refresh with citrus</td>
</tr>
<tr>
<td class="label">Evening</td>
<td>Relaxation oil (lavender)</td>
</tr>
<tr>
<td class="label">Daily</td>
<td>Olfactory training</td>
</tr>
<tr>
<td class="label">Resource</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Tisserand Institute</td>
<td>Essential oil safety</td>
</tr>
<tr>
<td class="label">National Association for Holistic Aromatherapy</td>
<td>Education and protocols</td>
</tr>
<tr>
<td class="label">Alliance of International Aromatherapists</td>
<td>Standards and certification</td>
</tr>
<tr>
<td class="label">Parkinson's Foundation</td>
<td>Olfactory resources</td>
</tr>
<tr>
<td class="label">Related Topic</td>
<td>Link</td>
</tr>
<tr>
<td class="label">Mindfulness</td>
<td>[Section 230: Mindfulness](/therapeutics/section-230-advanced-mindfulness-meditation-cbs-psp)</td>
</tr>
<tr>
<td class="label">Yoga and Mind-Body</td>
<td>[Section 231: Yoga](/therapeutics/section-231-advanced-yoga-mind-body-therapy-cbs-psp)</td>
</tr>
<tr>
<td class="label">Acupuncture and TCM</td>
<td>[Section 234: Acupuncture/TCM](/therapeutics/section-234-advanced-acupuncture-tcm-cbs-psp)</td>
</tr>
<tr>
<td class="label">Music Therapy</td>
<td>[Section 181: Music/Rhythm](/therapeutics/section-181-advanced-music-rhythm-therapy-cbs-psp)</td>
</tr>
<tr>
<td class="label">Clinical Management</td>
<td>[Clinical Management Guide](/therapeutics/clinical-management-guide-cbs-psp)</td>
</tr>
<tr>
<td class="label">Autonomic Dysfunction</td>
<td>[PSP Autonomic Mechanisms](/mechanisms/psp-autonomic-dysfunction)</td>
</tr>
<tr>
<td class="label">Quality of Life</td>
<td>[PSP Quality of Life](/diseases/psp-quality-of-life-caregiver)</td>
</tr>
</table>
Aromatherapy and olfactory stimulation represent emerging non-pharmacological interventions for corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These approaches target the olfactory system, which has direct connections to limbic structures, autonomic centers, and cognitive networks. Olfactory dysfunction is common in neurodegenerative diseases, with prevalence exceeding 70% in PSP patients[@hanshin2020], making targeted olfactory interventions strategically relevant for supporting neuroplasticity, stress reduction, autonomic regulation, and quality of life improvement.
The olfactory system maintains unique regenerative capacity through continuous neurogenesis in the olfactory epithelium, offering a potential therapeutic window for neurodegenerative conditions. Additionally, essential oils contain bioactive compounds that may exert neuroprotective, anti-inflammatory, and mood-modulating effects through both olfactory and systemic pathways.
1. Neurobiological Mechanisms
1.1 Olfactory System and Neurodegeneration
The olfactory system serves as a gateway between the external environment and the brain, with direct neural connections bypassing traditional blood-brain barriers:
Olfactory dysfunction in CBS/PSP correlates with disease progression and may serve as both a biomarker and therapeutic target. The olfactory bulb shows early pathology in tauopathies.
1.2 Prevalence and Clinical Significance
1.3 Limbic System Modulation
Aromatherapy stimulates limbic structures through olfactory input:
- Amygdala: Emotional processing and stress response
- Hippocampus: Memory consolidation and spatial navigation
- Anterior cingulate: Attention and emotional regulation
- Hypothalamus: Autonomic and endocrine coordination
1.4 Autonomic Regulation
Olfactory stimulation modulates autonomic nervous system function:
Evidence supports aromatherapy effects on autonomic function in Parkinson's disease[@hirayama2021].
1.5 Anti-Inflammatory and Neuroprotective Effects
Essential oil constituents demonstrate neuroprotective properties:
Pre-clinical evidence shows essential oil inhalation may reduce neuroinflammation in parkinsonian models[@suzuki2023].
1.6 Olfactory Neurogenesis
The olfactory epithelium maintains continuous neurogenesis throughout life:
- Basal cells differentiate into olfactory receptor neurons
- Olfactory bulb maintains neurogenic niches
- Environmental enrichment supports olfactory neurogenesis
- Olfactory stimulation promotes neuronal differentiation
This regenerative capacity provides a rationale for olfactory training as a neuroplasticity-promoting intervention[@morita2022].
2. Essential Oils for CBS/PSP
2.1 Classification and Properties
Essential oils suitable for CBS/PSP intervention:
2.2 Cognitive Support Oils
For cognitive enhancement in CBS/PSP:
2.3 Mood and Anxiety Oils
For emotional regulation and anxiety:
2.4 Autonomic Modulation Oils
For autonomic regulation:
2.5 Safety Considerations
3. Aromatherapy Protocols
3.1 Diffusion Methods
Passive Diffusion
Method: Ultrasonic diffuser disperses essential oil particles into air
CBS/PSP Adaptations:
- Use in well-ventilated areas
- Ensure caregiver presence for safety
- Start with single oils before blends
- Monitor for respiratory irritation
Active Inhalation
Method: Direct inhalation from bottle or tissue
3.2 Topical Applications
Dilution Guidelines
3.3 CBS/PSP-Specific Protocols
Morning Cognitive Protocol
Evening Relaxation Protocol
3.4 Stage-Based Protocols
Early Stage (Hoehn-Yahr 1-2)
- Full aromatherapy protocols
- Multiple daily sessions
- Active participation in selection
- Complex blends possible
Mid Stage (Hoehn-Yahr 3)
- Simplified protocols
- Caregiver assistance
- Shorter sessions
- Focus on relaxation
Late Stage (Hoehn-Yahr 4-5)
- Minimal intervention
- Caregiver-led
- Gentle scents only
- Focus on comfort
4. Olfactory Training (Smell Retraining Therapy)
4.1 Evidence Base
Olfactory training promotes olfactory receptor regeneration and functional recovery:
4.2 Training Protocol
Standard Protocol
CBS/PSP Adaptations
4.3 Technique
Steps:
4.4 Monitoring
5. Integrated Therapeutic Approaches
5.1 Aromatherapy with Mindfulness
Combining aromatherapy with mindfulness enhances both interventions:
- Enhanced relaxation
- Improved attention
- Emotional processing
- Stress reduction
5.2 Aromatherapy with Music Therapy
Synergistic effects from combined sensory stimulation:
- Use compatible oils and music genres
- Lavender with calming classical
- Citrus with upbeat instrumental
5.3 Aromatherapy with Physical Therapy
5.4 Memory and Cognition Protocol
Components:
Evidence: Rosemary shows acetylcholinesterase inhibition, potentially supporting memory function.
6. Clinical Integration
6.1 Assessment Protocol
6.2 Safety Monitoring
6.3 Documentation
Patient Log:
7. Evidence Summary
7.1 Clinical Evidence
7.2 Evidence in CBS/PSP
7.3 Mechanistic Evidence
7.4 Gaps and Limitations
- Limited CBS/PSP-specific trials
- Small sample sizes in existing studies
- Variable methodologies
- Need for standardized protocols
8. NET Assessment
9. Drug Interactions
9.1 Levodopa Considerations
9.2 Antidepressant Considerations
9.3 General Recommendations
- No significant drug interactions
- Aromatherapy may enhance mood medications
- Essential oils generally safe with neurological medications
- Monitor for additive CNS effects
10. Patient Action Items
10.1 Getting Started
10.2 Recommended Daily Practice
10.3 Resources
10.4 Goals by Timeframe
30-Day Goals:
- Complete 20+ sessions
- Identify preferred oils
- 30-day practice streak
- Begin olfactory training protocol
- Document quality of life changes
- Maintained daily practice
- Completed olfactory training phases
- Documented benefit assessment
11. Cross-Links
References
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — <span style="color:#ffd54f;font-weight:600">0.44</span> · Target: TH, AADC
- [Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7
- [Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: PIEZO1 and KCNK2
- [Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: DGAT1 and SOAT1
- [Vocal Cord Neuroplasticity Stimulation](/hypothesis/h-e0183502) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: CHR2/BDNF
- [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
- [Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
- [What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) 🔄
- [Digital biomarkers and AI-driven early detection of neurodegeneration](/analysis/SDA-2026-04-01-gap-012) 🔄
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | therapeutics-section-238-aromatherapy-olfactory-stimulation-cbs-psp |
| kg_node_id | None |
| entity_type | therapeutic |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-c0b8dbfaed68 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-section-238-aromatherapy-olfactory-stimulation-cbs-psp'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-therapeutics-section-238-aromatherapy-olfactory-stimulation-cbs-psp?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP](http://scidex.ai/artifact/wiki-therapeutics-section-238-aromatherapy-olfactory-stimulation-cbs-psp)
http://scidex.ai/artifact/wiki-therapeutics-section-238-aromatherapy-olfactory-stimulation-cbs-psp